Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092697 | SCV001249329 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | DENND5A: BP4, BP7, BS2 |
Labcorp Genetics |
RCV001092697 | SCV002426767 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001092697 | SCV005221284 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003963037 | SCV004779550 | benign | DENND5A-related disorder | 2023-12-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |